Assiut University
Asyut, Egypt
NCT Number: NCT07200869
This study aims to assess the incidence and clinical outcomes of vaso-occlusive crises in pediatric patients with sickle cell disease. Data will be collected and analyzed to identify risk factors and related complications.
Trial opening soon.
Get Notified1 year–18 year
All sexes
Observational
Asyut, Egypt
Sickle cell disease is a hereditary blood disorder characterized by the presence of sickle-shaped red blood cells, which leads to recurrent vaso-occlusive crises (VOC). These painful episodes are among the most common causes of hospitalization and are associated with significant morbidity in pediatric patients. Despite ongoing improvements in the management of sickle cell disease, there is still limited data describing the incidence, risk factors, and clinical outcomes of VOC in children within our population.
This study is designed to retrospectively analyze medical records of pediatric patients with sickle cell disease at Faculty of Medicine, Assiut University. The primary aim is to estimate the incidence of vaso-occlusive crises and to identify the most frequent complications. Secondary objectives include evaluating treatment approaches, length of hospital stay, and clinical outcomes. Findings from this study are expected to provide valuable insights that may help improve clinical care strategies and preventive measures for affected children.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
History of at least one hospital visit or admission for vaso-occlusive crisis
Exclusion criteria
retrospective observational study. No intervention will be administered; data will be collected from existing medical records of pediatric sickle cell patients at Assiut University Hospital.
Time frame: Retrospective review of medical records from 2019 to 2024
Frequency of vaso-occlusive crisis episodes will be identified through retrospective chart review of pediatric sickle cell patients.
Time frame: Throughout the study period (2019-2024)
Complications related to vaso-occlusive crisis will be identified and documented from patient records.
Contact information is provided by the study sponsor or research team.
Assiut University research office
CONTACT
Nadia Fawzy, Pediatrician
CONTACT
+201552865958 ext. +201552865958
Assiut University
Other
Vaso-occlusive Crisis Incidence and Outcomes in a Pediatric Sickle Cell Population
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03353584
Anemia, Anemia, Hemolytic
Memphis, Tennessee, United States
View Trial DetailsNCT01891812
Anemia, Anemia, Hemolytic
New York, United States
View Trial DetailsNCT04935879
Anemia, Anemia, Hemolytic
Mobile, Alabama, United States
View Trial DetailsNCT06345638
Anemia, Anemia, Hemolytic
Philadelphia, Pennsylvania, United States
View Trial Details